NATCO PHARMA LTD.

  • NSE : NATCOPHARM
  • BSE : 524816
  • ISIN CODE : INE987B01026
  • Industry : Pharmaceuticals & Drugs
  • House : Natco

BSE

978.85 5.30 (0.54 %)

Prev Close ( ) 973.55

Open Price ( ) 0.00

BID Price (QTY) 1017.35 (5)

Offer Price (QTY) 940.00 (200)

Volume 0

Today's Low / High ( )

0.00
0.00

52 WK Low / High ( )

660.05
1638.35

NSE

973.60 0.00 (0.00 %)

Prev Close ( ) 973.60

Open Price ( ) 928.00

BID Price (QTY) 0.00 (0)

Offer Price (QTY) 973.60 (932)

Volume 5926568

Today's Low / High ( )

928.00
977.00

52 WK Low / High ( )

726.80
1639.00

Stock Summary

Trade Value ( in Lacs) 0.00
Dividend Yield(%) 0.62
TTM EPS () 103.31
P/E Ratio 9.42
Book Value () 409.46
Face Value () 2
MCap ( in Mn) 174372.41
Price/Earning (TTM) 8.42
Price/Sales (TTM) 4.26
Price/Book (MRQ) 2.38
PAT Margin (%) 34.77
ROCE (%) 29.02

Peer Group

Financials

in Millions
QTR Mar 24 ANNUAL 24
Net Profit 0.00 13066.00
Gross Profit 0.00 15553.00
Operating Profit 0.00 17417.00
Net Sales 0.00 35689.00

Shareholding Pattern

Promoters 0%
Non-Institution 0%
Fi / Banks / Insurance 0%
Mutual Funds / UTI 0%
Government 0%
FII 0%
Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office
Address

Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500034

Phone

040-23547532

Registrars Details
Venture Capital & Corporate Investments Ltd

Aurum, Door No 4-50/P-II/57/4F&5F Plot No 57,4th & 5th Floors,Jayabheri Enclave Phase - II, Gachibowli,Hyderabad

Listing : BSE, NSE

Event Calendar

Rolling Forward P/E (EOD)

About Natco Pharma Ltd.

Natco Pharma Limited is a vertically integrated and R&D focused pharmaceutical company engaged in developing, manufacturing and marketing of finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company manufactures API products which are primarily used for captive consumption in its FDF products and are also sold to customers for various international markets. In the API segment, company has capabilities to develop and manufacture products with multi-step synthesis, semi synthetic fusion technologies, high-potency APIs and peptides. It is also engaged in contract manufacturing business, whereby it undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. It has diversified into the business of crop health sciences to leverage is skills in organic chemistry.